Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 72.20
+1.30 (1.83%)
Sep 25, 2026, 5:35 PM CET
Pharmanutra Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 143.7 | 132.16 | 116.15 | 100.71 | 83.06 | 68.14 |
Revenue Growth | 17.94% | 13.78% | 15.33% | 21.24% | 21.89% | 20.04% |
Gross Profit Gross Profit Growth | 72.27 | 66.79 | 59.24 | 48.62 | 41.92 | 32.15 |
Operating Income Operating Income Growth | 30.64 | 29.1 | 27.36 | 23.02 | 23.07 | 18.3 |
Net Income Net Income Growth | 20.74 | 20 | 16.61 | 12.83 | 15.05 | 13.77 |
Earnings Per Share EPS Growth | 2.17 | 2.09 | 1.73 | 1.33 | 1.56 | 1.42 |
EPS Growth | 22.92% | 20.63% | 30.29% | -14.69% | 9.37% | -2.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Instruments Medical Instruments Growth | 7.08 | 6.82 | 5.92 | 5.03 | 2.03 | - |
Rest of World Rest of World Growth | 55.47 | 48.25 | 39.34 | 31.61 | 23.4 | 20.3 |
Italy Italy Growth | 80.21 | 76.63 | 70.24 | 63.56 | 57.97 | 47.81 |
Total Total Growth | 142.76 | 131.69 | 115.5 | 100.2 | 83.39 | 68.11 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15.14 | 30.62 | 28.97 | 25.12 | 26.86 | 33.94 |
Total Debt Total Debt Growth | 18.36 | 20.51 | 24.27 | 28.02 | 17.73 | 6.35 |
Net Cash (Debt) Net Cash Growth | -3.22 | 10.1 | 4.7 | -2.9 | 9.14 | 27.59 |
Net Cash Growth | - | 114.91% | - | - | -66.89% | 44.14% |
Net Cash Per Share Net Cash Per Share Growth | -0.34 | 1.05 | 0.49 | -0.30 | 0.94 | 2.85 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19.08 | 19.56 | 20.42 | 12.09 | 17.47 | 20.41 |
Capital Expenditures CapEx Growth | -4.05 | -3.13 | -4.25 | -13.25 | -26.16 | -4.99 |
Free Cash Flow Free Cash Flow Growth | 15.02 | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 |
Free Cash Flow Growth | 85.17% | 1.59% | - | - | - | 52.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.29% | 50.54% | 51.00% | 48.28% | 50.47% | 47.18% |
Operating Margin | 21.32% | 22.02% | 23.55% | 22.86% | 27.78% | 26.85% |
Pretax Margin | 21.55% | 22.84% | 23.38% | 23.10% | 28.19% | 27.60% |
Profit Margin | 14.44% | 15.14% | 14.30% | 12.74% | 18.12% | 20.21% |
FCF Margin | 10.46% | 12.43% | 13.92% | -1.15% | -10.46% | 22.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 1.200 | 1.000 | 0.850 | 0.800 | 0.710 |
Dividend Per Share Growth | 20.00% | 20.00% | 17.65% | 6.25% | 12.68% | 5.97% |
Dividend Yield | 1.66% | 2.24% | 1.90% | 1.58% | 1.37% | 1.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.35 | 26.07 | 31.47 | 42.26 | 39.94 | 53.01 |
Forward PE | 25.36 | 23.47 | 25.25 | 32.36 | 38.79 | 53.54 |
P/FCF Ratio | 46.02 | 31.74 | 32.32 | - | - | 47.32 |
PS Ratio | 4.81 | 3.95 | 4.50 | 5.39 | 7.24 | 10.71 |